Citation: Wa. Deboer et al., 4-DAY LANSOPRAZOLE-QUADRUPLE THERAPY IN THE ROUTINE TREATMENT OF HELICOBACTER-PYLORI INFECTION, Netherlands journal of medicine, 52(1), 1998, pp. 10-15
Citation: Wa. Deboer, DUODENAL STENOSIS DOES REGRESS AFTER ERADICATION OF HELICOBACTER-PYLORI, Journal of clinical gastroenterology, 26(4), 1998, pp. 357-357
Citation: Wa. Deboer et Tj. Borody, TOWARDS MONOTHERAPY FOR HELICOBACTER-PYLORI INFECTION - FIRST RESULTSWITH A SINGLE TRIPLE CAPSULE, Gastroenterology, 114(4), 1998, pp. 402-402
Citation: Rjf. Laheij et al., DIAGNOSTIC PERFORMANCE OF BIOPSY-BASED METHODS FOR DETECTION OF HELICOBACTER-PYLORI INFECTION IN ROUTINE CLINICAL CARE, Gastroenterology, 114(4), 1998, pp. 784-784
Citation: Wa. Deboer et al., OPTIMAL TREATMENT OF HELICOBACTER-PYLORI WITH RANITIDINE BISMUTH CITRATE (RBC) - A RANDOMIZED COMPARISON BETWEEN 2 7-DAY TRIPLE THERAPIES AND A 14-DAY DUAL THERAPY, The American journal of gastroenterology, 93(7), 1998, pp. 1101-1107
Citation: Wa. Deboer, DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION - REVIEW OF DIAGNOSTIC-TECHNIQUES AND RECOMMENDATIONS SETTINGS, Scandinavian journal of gastroenterology, 32, 1997, pp. 35-42
Citation: Bam. Vandewouw et al., USEFULNESS OF THE C-14 UREA BREATH TEST AS A SEMIQUANTITATIVE MONITORING INSTRUMENT AFTER THERAPY FOR HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 32(2), 1997, pp. 112-117
Citation: Wa. Deboer et al., 4 DAYS LANSOPRAZOLE-QUADRUPLE THERAPY IN THE ROUTINE TREATMENT OF HELICOBACTER-PYLORI INFECTION, Gut, 41, 1997, pp. 101-101
Authors:
DEBOER WA
THYS JC
BORODY TJ
GRAHAM DY
OMORAIN C
TYTGAT GNJ
Citation: Wa. Deboer et al., PROPOSAL FOR USE OF A STANDARD SIDE-EFFECT SCORING SYSTEM IN STUDIES EXPLORING HELICOBACTER-PYLORI TREATMENT REGIMENS, European journal of gastroenterology & hepatology, 8(7), 1996, pp. 641-643
Citation: Wa. Deboer et Gnj. Tytgat, HOW TO TREAT HELICOBACTER-PYLORI INFECTION - SHOULD TREATMENT STRATEGIES BE BASED ON TESTING BACTERIAL SUSCEPTIBILITY - A PERSONAL VIEWPOINT, European journal of gastroenterology & hepatology, 8(7), 1996, pp. 709-716
Authors:
VANZWET AA
DEBOER WA
SCHNEEBERGER PM
WEEL J
JANSZ AR
THIJS JC
Citation: Aa. Vanzwet et al., PREVALENCE OF PRIMARY HELICOBACTER-PYLORI RESISTANCE TO METRONIDAZOLEAND CLARITHROMYCIN IN THE NETHERLANDS, European journal of clinical microbiology & infectious diseases, 15(11), 1996, pp. 861-864
Authors:
LAI JYL
DEBOER WA
DRIESSEN WMM
GEUSKENS LM
Citation: Jyl. Lai et al., LONG-TERM FOLLOW-UP AFTER CURE OF HELICOBACTER-PYLORI INFECTION WITH 4 DAYS OF QUADRUPLE THERAPY, Alimentary pharmacology & therapeutics, 10(4), 1996, pp. 645-650
Citation: Wa. Deboer, HOW TO ACHIEVE A NEAR 100-PERCENT CURE RATE FOR HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER PATIENTS - A PERSONAL VIEWPOINT, Journal of clinical gastroenterology, 22(4), 1996, pp. 313-316
Authors:
VANDEWOUW BAM
DEBOER WA
JANSZ AR
ROYMANS RTJM
STAALS APG
Citation: Bam. Vandewouw et al., COMPARISON OF 3 COMMERCIALLY AVAILABLE ENZYME-LINKED IMMUNOSORBENT ASSAYS AND BIOPSY-DEPENDENT DIAGNOSIS FOR DETECTING HELICOBACTER-PYLORI INFECTION, Journal of clinical microbiology, 34(1), 1996, pp. 94-97
Authors:
DEBOER WA
VANETTEN RJXM
SCHADE RWB
OUWEHAND ME
SCHNEEBERGER PM
TYTGAT GNJ
Citation: Wa. Deboer et al., 4-DAY LANSOPRAZOLE QUADRUPLE THERAPY - A HIGHLY EFFECTIVE CURE FOR HELICOBACTER-PYLORI INFECTION, The American journal of gastroenterology, 91(9), 1996, pp. 1778-1782
Citation: Wa. Deboer et Ta. Vanzwet, DIAGNOSE AND TREAT HELICOBACTER-PYLORI AS ANY OTHER INFECTIOUS-DISEASE, The American journal of gastroenterology, 91(10), 1996, pp. 2255-2255